跳至主要内容
临床试验/NCT03806777
NCT03806777Unknown4 期

Intra-nasal Dexmedetomidine for Children Undergoing MRI Imaging

University of British Columbia0 个研究点目标入组 180 人开始时间: 2019年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
180
主要终点
Dose

研究概览

简要总结

This study aims to assess the use of intranasal dexmedetomidine (IN-dex) as a sole agent in aiding the successful completion of a MRI scans in children. Dexmedetomidine, a routinely used anesthetic agent in our institution, has many benefits including sedation with neuro-protective and respiratory sparing features. We will test its effectiveness in completing MRI scans in children that would otherwise be given a full general anesthetic.

详细描述

Purpose:

To assess the use of IN-dex as a sole agent in aiding the successful completion of a MRI scan in children.

Hypothesis:

We hypothesize that the optimal dose for IN-dex to produce appropriate sedation for MRI will be between 1 and 3 mcg/kg. We also hypothesize that this dose will be lower in the older age group.

Justification:

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
3 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • ASA 1 or 2
  • Scheduled for elective MRI scan on the general anesthesia list
  • Child Life MRI simulation score of 6-10 (Figure 1)
  • Age 3 - 18

排除标准

  • Taking existing opioid, sedative, or cannabinoid medication
  • Severe learning disability defined as the inability to follow simple commands
  • Severe Cardiac disease
  • Chronic hypertension
  • Allergy to dexmedetomidine
  • Nasal anatomical abnormality
  • Known or anticipated difficult airway

研究组 & 干预措施

Intra-nasal dexmedetomidine

Experimental

A single dose of dexmedetomidine, determined by a biased coin algorithm (min: 1 mcg/kg; max: 4 mcg/kg or 200mcg), will be delivered intranasally 45min before an MRI scan.

干预措施: Dexmedetomidine (Drug)

结局指标

主要结局

Dose

时间窗: Immediately after completion of the MRI scan.

The intranasal dexmedetomidine dose in mcg/kg that produces successful completion of MRI scan with acceptable MRI image quality in 90% of individuals (ED 90).

次要结局

  • Uninterrupted scans(Immediately after completion of the MRI scan.)
  • Respirator support(During MRI scan)
  • Adverse events(During MRI scan)
  • modified Yale Preoperative Anxiety Scale (mYPAS)(Immediately before administration of intranasal dexmedetomidine)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mark Ansermino

Associate Professor

University of British Columbia

相似试验